A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tazarotene
Eculizumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Eculizumab.
Tazarotene
Docetaxel
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Docetaxel.
Tazarotene
Dexamethasone
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Dexamethasone.
Tazarotene
Lomustine
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Lomustine.
Tazarotene
Mitoxantrone
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Mitoxantrone.
Tazarotene
Estramustine
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Estramustine.
Tazarotene
Ifosfamide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Ifosfamide.
Tazarotene
Idarubicin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Idarubicin.
Tazarotene
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Arsenic trioxide.
Tazarotene
Trilostane
The risk or severity of adverse effects can be increased when Trilostane is combined with Arsenic trioxide.
Tazarotene
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Arsenic trioxide.
Tazarotene
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Arsenic trioxide.
Tazarotene
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Arsenic trioxide.
Tazarotene
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Arsenic trioxide.
Tazarotene
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Arsenic trioxide.
Tazarotene
Azacitidine
The risk or severity of adverse effects can be increased when Azacitidine is combined with Arsenic trioxide.
Tazarotene
Mechlorethamine
The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Arsenic trioxide.
Tazarotene
Temozolomide
The risk or severity of adverse effects can be increased when Temozolomide is combined with Arsenic trioxide.
Tazarotene
Dacarbazine
The risk or severity of adverse effects can be increased when Dacarbazine is combined with Arsenic trioxide.
Tazarotene
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Arsenic trioxide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3